Meatable: Cell-based meat startup secures $47m Series A for scalable technology

Co-founders De Nood (L) and Luining © Meatable

The Dutch startup offers a pioneering technology for quickly scaling cell-based meat production while eliminating the need for animal-derived growth media

00:00/00:00
The race is on in the increasingly crowded cell-based meat space to provide an affordable, industrially scalable production method, but cultured meat production now relies on the use of expensive Fetal Bovine Serum (FBS) as the culture media. Also, FBS is derived from blood collected from the calves of pregnant dairy cows at slaughter, but eliminating animal cruelty is a key tenet of cell-based meat production.Dutch startup Meatable has developed a feasible solution to these problems using a cell-programming technology called OPTi-OX developed in 2014, which, in turn, was based on Nobel Prize-...
Limited Reading

The rest of the content is only available if you are logged in.

Limited Reading

Edited by S. Mani

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using www.compasslist.com and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.